Prophylactic use of antibiotics and vaccines in patients with rheumatologic disorders

Rheumatic Disease Clinics of North America

Volumn 23, Issue 2, 1997, Pages 259-275

  Mounzer, K C ^a   DiNubile, M J ^a  

^a Education and Research Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VACCINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CELLULAR IMMUNITY; COMPLEMENT SYSTEM; COST EFFECTIVENESS ANALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOPROPHYLAXIS; INFECTION; MORBIDITY; MORTALITY; PHAGOCYTE; PRIORITY JOURNAL; RHEUMATIC DISEASE; STEROID THERAPY; TUBERCULIN TEST;

EID: 0031009217     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70329-X     Document Type: Article

References (84)

1. Ad Hoc Committee of the Scientific Assembly on Microbiology, Tuberculosis, and Pulmonary Infections Treatment of tuberculosis and tuberculosis infection in adults and children Clin Infect Dis 21 1995 9 27
2. V. Agnello Complement deficiency states Medicine 57 1978 1 23
3. H.H. Balfour Jr Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment Scand J Infect Dis 80 suppl 1991 69 74
4. D.T. Boumpas G.P. Chrousos J.E. Balow Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates Ann Intern Med 119 1993 1198 1208
5. D.T. Boumpas F. Paliogianni E.D. Anastassiou Glucocorticosteroid action on the immune system: Molecular and cellular aspects Clin Exp Rheumatol 92 1993 223 228
6. H. Buckley Immunodeficiency diseases JAMA 268 1992 2797 2806
7. J. Carrafala R. Moreno I. Moga Neisseria meningitides monoarthritis revealing systemic lupus erythematosus [letter] J Rheumatol 15 1988 532
8. F.J. Catanzaro C.A. Stetson A.J. Morris Symposium on rheumatic fever and rheumatic heart disease: The role of streptococcus in the pathogenesis of rheumatic fever Am J Med 17 1954 749 756
9. Centers for Disease Control Revised dosing regimen for malaria prophylaxis with mefloquine MMWR Morb Mortal Wkly Rep 39 1990 630
10. Centers for Disease Control and Prevention Prevention and control of influenza. Part 1. Vaccines. Recommendations of the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep 42 1993 1 14
11. Centers for Disease Control and Prevention Prevention of varicella: Recommendation of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 45 1996 1 43
12. Centers for Disease Control and Prevention Recommendation of the advisory committee for elimination of tuberculosis MMWR Morb Mortal Wkly Rep 39 1990 9 15
13. Centers for Disease Control and Prevention Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence MMWR Morb Mortal Wkly Rep 42 1993 1 18
14. Centers for Disease Control and Prevention Recommendations of the Immunization Practice Advisory Committee (ACIP): Pneumococcal polysaccharide vaccine MMWR Morb Mortal Wkly Rep 38 1989 64 75
15. Centers for Disease Control and Prevention Recommendation of the Immunization Practices Advisory Committee (ACIP). Poliomyelitis preventions: Enhanced potency inactivated poliomyelitis vaccine—Supplementary statement MMWR Morb Mortal Wkly Rep 36 1987 795 798
16. Centers for Disease Control and Prevention Recommendation of the Immunization Practices Advisory Committee (ACIP): Use of BCG vaccines in the control of tuberculosis: A joint statement by the ACIP and the Advisory Committee for elimination of tuberculosis MMWR Morb Mortal Wkly Rep 37 1988 663 664 669–675,
17. Centers for Disease Control and Prevention Update: Recommendations to prevent hepatitis B virus transmission—United States MMWR Morb Mortal Wkly Rep 44 1995 574 575
18. H.N. Claman The biology of the immune response JAMA 268 1992 2790 2796
19. D.C. Classen R.S. Evans J.P. Burke The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection N Engl J Med 326 1992 281 286
20. S.M. Croft G. Schiffman E. Snyder Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus J Rheumatol 11 1984 141 146
21. A.S. Dajani A.L. Bisno K.J. Chung Prevention of bacterial endocarditis. Recommendations by the American Heart Association JAMA 264 1990 2919 2922
22. D.C. Dale A.S. Fauci S.M. Wolff Alternate-day prednisone: Leukocyte kinetics and susceptibility to infection N Engl J Med 291 1974 1154 1158
23. A.M. Dillon H.B. Stein J.W. Ibbott Hyposplenia in a patient with systemic lupus erythematosus J Rheumatol 7 1980 196 198
24. M.J. DiNubile A. Albronoz A.R. Myers Pneumococcal soft-tissue infections: Possible association with connective tissue diseases J Infect Dis 163 1991 897 900
25. J.F. Enders K. McCarthy A. Mitus Isolation of measles virus at autopsy in cases of giant cell pneumonia without rash N Engl J Med 261 1959 875
26. J.A. Englund M.E. Zimmerman H.H. Balfour Herpes simplex virus resistant to acyclovir: A study in a tertiary care center Ann Intern Med 112 1990 416 422
27. K.S. Erlich J. Mills C.S. Crumpacker Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome N Engl J Med 320 1989 293 296
28. E.D. Chernak M.J. DiNubile Infections in the pharmacologically immunocompromised host B.F. Mandell Acute Rheumatic and Immunological Diseases: Management of Critically Ill Patients 1994 Marcel Dekker New York 27 56
29. P.T. Fan P.J. Clements R. Bluestone Effects of corticosteroids on the human immune response: Comparison of 1 and 3 daily 1 Gr intravenous pulses of methylprednisolone J Lab Clin Med 91 1978 625 634
30. D.S. Fedson Adult immunization: Summary of the National Vaccine Advisory Committee Report JAMA 272 1994 1133 1137
31. J.E. Figueroa P. Densen Infectious diseases associated with complement deficiencies Clin Microbiol Rev 4 1991 359 395
32. A. Fischer Severe combined immunodeficiencies Immunodeficiency Rev 3 1992 83 100
33. J.K. Frenkel Role of corticosteroids as predisposing factors in fungal diseases Lab Invest 11 1962 1192 1208
34. Friedman L. Ross J.D. Lantos Immunization against chickenpox BMJ 310 1995 2 3
35. T.F. Gajewski M. Pinnas T. Wong Mazine TH, and TH2 clones proliferate optimally in response to distinct antigen-presenting cell populations J Immunol 146 1991 1750 1758
36. A.A. Gershon Live attenuated varicella vaccine J Infect Dis 152 1985 859 862
37. A.A. Gershon P. LaRussa I. Hardy Varicella vaccine: The American experience J Infect Dis 166 1992 563 568
38. E. Ginzler H. Diamond D. Kaplan Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus Arthritis Rheum 21 1978 37 44
39. B. Godeau D.L. Mainarti J.C. Piette Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis Ann Rheum Dis 54 1995 991 994
40. I. Hardy A.A. Gershon S.P. Steinberg The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group N Engl J Med 325 1991 1545 1550
41. D.B. Hellmann M. Petri Q. Whiting-O'Keefe Fatal infections in systemic lupus erythematosus: The role of opportunistic organisms Medicine 66 1987 341 348
42. M.P. Jarrett G. Schiffman P. Barland Impaired response to pneumococcal vaccine in systemic lupus erythematosus Arthritis Rheum 23 1980 1287 1293
43. L.J. Kaplan R.S. Daum M. Smaron Severe measles in immunocompromised patients JAMA 267 1992 1237 1241
44. J.H. Klippel H.A. Austin III J.E. Balow Studies of immunosuppressive drugs in the treatment of lupus nephritis Rheum Dis Clin North Am 13 1987 47 56
45. R.I. Lehrer T. Ganz J.T. Curnutte Neutrophils and host defense Ann Intern Med 109 1988 127 142
46. J.S. Louie K.M. Nies D. Imagawa Clinical and antibody responses after influenza immunization in systemic lupus erythematosus Ann Intern Med 88 1978 790 792
47. E.B. Luce M.T. Montgomery S.W. Redding The prevalence of cardiac valvular pathosis in patients with systemic lupus erythematosus Oral Surg Oral Med Oral Pathol 70 1990 590 592
48. H.C. Lue M. Wu K. Hsieh Rheumatic fever recurrences: Controlled study of three-week vs four-week benzathine penicillin prevention programs J Pediatr 108 1986 299 304
49. S. Martinez-Cairo Cueto M.L. Ramirez-Lacayo P. Veladiz-Saint-Martin Deterioration of intracellular destruction capacity of S. aureus in children with systemic lupus erythematosus Archives of Investigational Medicine (Mexico) 17 1986 25 36
50. H. Masur Prevention and treatment of pneumocystis pneumonia N Engl J Med 327 1992 1853 1860
51. W.J. Matrone R.W. Zaehl G.E. Minson Postsplenectomy sepsis with DF-2: Report of a case with isolation of the organism from the patient's dog Ann Intern Med 93 1980 457 458
52. M.C. Morgan E. Matteson R. Dunne Complications of intravenous cyclophosphamide: Association of infections with high daily doses of prednisone in lupus patients [abstract] Arthritis Rheum 28 suppl 1990 R27
53. A.G. Mulley M.D. Silverstein J.L. Dienstag Indications for the use of hepatitis B vaccine, based on cost-effectiveness analysis N Engl J Med 307 1982 644 652
54. B.A. Neilan S.N. Barney Hyposplenism in systemic lupus erythematosus J Rheumatol 10 1983 332 334
55. C. Norden A critical review of antibiotic prophylaxis in orthopedic surgery Rev Infect Dis 5 1983 928 932
56. W.A. O'Brien K. Grovit-Forbas J.A. Zack Human immunodeficiency virus type I replication can be increased in peripheral blood of seropositive patients after influenzae vaccination Blood 86 1995 1082 1089
57. J.E. Parillo A.S. Fauci Mechanism of glucocorticoid action on immune processes Annu Rev Pharmacol Toxicol 19 1979 179 201
58. H.D. Perez R.I. Andron I.M. Goldstein Infection in patients with systemic lupus erythematosus. Association with a serum inhibitor of complement-derived chemotactic activity Arthritis Rheum 22 1979 1326 1333
59. M.E. Pichichero P.A. Margolis A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial copathogenicity Pediatr Infect Dis J 10 1991 275 281
60. R.W. Pinner B.G. Gellin C.V. Broone Meningococcal disease in the United States J Infect Dis 164 1991 368 374
61. S.C. Ristow G.R. Douglas Jr J.J. Condemi Influenza vaccination of patients with systemic lupus erythematosus Ann Intern Med 88 1978 786 789
62. C.T. Ritchlin J.S. Dobro J.P. Buyon Opportunistic infections in patients with systemic lupus erythematosus [abstract] Arthritis Rheum 31 suppl 1988 R4
63. P.J. Roberts D.A. Isenberg A.W. Segal Defective degradation of bacterial DNA by phagocytes from patients with systemic and discoid lupus erythematosus Clin Exp Immunol 69 1987 68 78
64. A.C. Roldan K.B. Shively H.M. Crawford Echocardiographic study of valvular heart disease associated with systemic lupus erythematosus N Engl J Med 335 1996 1424 1430
65. J.E. Salmon R.P. Kimberly M. Fotino Defective mononuclear phagocyte function in SLE: Dissociation of Fc receptor-ligand binding and internalization J Immunol 133 1984 2525 2531
66. B.D. Schwartz Infectious agents, immunity, and rheumatic diseases Arthritis Rheum 33 1990 457 465
67. K.A. Sepkowitz Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: Who should receive prophylaxis? [Editorial] Mayo Clin Proc 71 1996 102 103
68. K.A. Sepkowitz A.E. Brown E.E. Telzak Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital JAMA 267 1992 832 837
69. E.D. Shapiro A.T. Berg R. Austrian The protective efficacy of polyvalent pneumococcal polysaccharide vaccine N Engl J Med 325 1991 1453 1460
70. J.B. Shiroky A. Frost J.D. Skelton Complications of immunosuppression associated with weekly low-dose methotrexate J Rheumatol 18 1991 1172 1175
71. R.V. Sims W.C. Steinmann J.S. Schwartz The clinical effectiveness of pneumococcal vaccine in the elderly Ann Intern Med 108 1988 653 657
72. J.E. Sisk R.K. Riegelman Cost effectiveness of vaccination against pneumococcal pneumonia: An update Ann Intern Med 104 1986 79 86
73. H.R. Smith A.D. Steinberg Autoimmunity—a perspective Annu Rev Immunol 1 1983 175 210
74. D.E. Snider Jr Bacille Calmette-Guérin vaccinations and tuberculin skin test JAMA 253 1985 3438 3439
75. C.A. Stegeman J.W. Cohen C.G.M. Kallenberg Trimethoprim-sulfamethoxazole (co-trimazole) for the prevention of relapses of Wegener's granulomatosis N Engl J Med 335 1996 16 20
76. B. Styrt Infections associated with asplenia: Risks, mechanisms, and prevention Am J Med 157 1992 440 443
77. J.A. Sullivan G.L. Mandell Motility of human polymorphonuclear neutrophils Journal of Reticuloendothelial Society 3 1983 31
78. D.A. Talan Infectious disease issues in the emergency department Clin Infect Dis 23 1996 1 14
79. Y. Tokano H. Yagita N. Iida Relation between the level of IgG subclasses and infections in patients with systemic lupus erythematosus Int Arch Allergy Immunol 87 1988 55 58
80. J.D. Urman N.F. Rothfield Corticosteroid treatment in systemic lupus erythematosus JAMA 238 1977 2272 2276
81. C. Van der Straeten N. Wei J. Rothschild Rapidly fatal pneumococcal septicemia in systemic lupus erythematosus J Rheumatol 14 1987 1177 1180
82. R.P. Wenzel Preoperative antibiotic prophylaxis N Engl J Med 325 1992 337 339
83. S.H. Yale A.H. Limper Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: Associated illness and prior corticosteroid therapy Mayo Clin Proc 71 1996 5 13
84. M.K. Zysset M.T. Montgomery S.W. Redding Systemic lupus erythematosus: A consideration for antimicrobial prophylaxis Oral Surg Oral Med Oral Pathol 64 1987 30 34